Sign in

What researchers published on Myeloproliferative neoplasms

7,956 papers, newest first.

Showing 200 of 7,956

  • CAR-T Targeting of Mutant Calreticulin Selectively Eradicates Myeloproliferative Neoplasm-Sustaining Stem Cells.Blood
  • How I diagnose myeloid or lymphoid neoplasms with tyrosine kinase gene fusions.American journal of clinical pathology
  • Low dose pre-transplant splenic radiotherapy for myeloproliferative neoplasms.Leukemia & lymphoma
  • Transfusion-related cost and time burden offsets associated with pacritinib versus best available therapy in patients with myelofibrosis: an economic evaluation based on the PERSIST-2 trial.Future oncology (London, England)
  • The new Iron Age in polycythemia vera.Blood
  • Case reportThrombocytapheresis for Extreme Thrombocytosis: A 20-Year Single-Center Experience With Acute and Chronic Use in Myeloproliferative Neoplasms.Journal of clinical apheresis
  • Case reportCase Report: Real-world experience with pacritinib after prior ruxolitinib exposure in myelofibrosis in Saudi Arabia: a report of five cases.Frontiers in medicine
  • Hematological trajectories and pregnancy complications in essential thrombocythemia and polycythemia vera.Annals of hematology
  • Effects of calreticulin mutations on HLA class I expression in myeloproliferative neoplasms.JCI insight
  • Portal and hepatic vein thrombosis in Philadelphia-negative myeloproliferative neoplasms: Insights from the National Inpatient Sample.Thrombosis research
  • ReviewSGLT2 Inhibitors and Hemoglobin Improvement in Myelodysplastic Syndromes and Myeloproliferative Neoplasms: Mechanistic Rationale and Emerging Clinical Evidence.Anemia
  • ReviewArterial thrombosis redirects the natural history of myeloproliferative neoplasms: A biological perspective.Annals of hematology
  • Association does not establish causation. Comment on: "Overuse of thrombopoietin receptor agonists driven by suboptimal response is associated with myelofibrosis in pediatric immune thrombocytopenia".Haematologica
  • Case report[Coronary Artery Bypass Grafting for Coronary Arteritis Induced by Myeloproliferative Neoplasms:Report of a Case].Kyobu geka. The Japanese journal of thoracic surgery
  • ReviewMomelotinib for the treatment of myelofibrosis in patients with moderate-to-severe anemia: a drug safety evaluation.Expert opinion on drug safety
  • Review[Clinical presentation, diagnosis, prognosis, and risk-adapted treatment of chronic BCR::ABL1-negative myeloproliferative neoplasms].Innere Medizin (Heidelberg, Germany)
  • High prevalence and immunophenotypic diversity of clonal T‑large granular lymphocytes in JAK2‑mutated myeloproliferative neoplasms.Annals of hematology
  • Case reportIsolated add(12)(p13) in a BCR::ABL1-Negative Neutrophilic Myeloproliferative Neoplasm Lacking Canonical Driver Mutations: A Case Report.Cureus
  • QRISK3 Assessment Identified Essential Thrombocythemia Patients at High Risk of Thrombotic Events Regardless of Revised IPSET-T Score and JAK2 Mutational Status.EJHaem
  • ReviewAdvances in Myeloproliferative Neoplasms by single-cell omics studies.Experimental hematology
  • ReviewRusfertide for the treatment of polycythemia vera.Expert opinion on pharmacotherapy
  • ReviewRopeginterferon alfa-2b for adults with polycythemia vera: an updated perspective from approval to real-world clinical treatment.Expert review of hematology
  • Systemic inflammation response index and total cholesterol in relation to the occurrence of major adverse cardiovascular and cerebrovascular events in patients with myeloproliferative neoplasms.BMC cardiovascular disorders
  • Clinical risk features and genetic findings in essential thrombocythemia and polycythemia vera of childhood and adolescence: prospective insights from the German MPN Childhood Registry.Haematologica
  • Case reportSubclonal AGGF1::PDGFRB rearrangement in a myelodysplastic/myeloproliferative neoplasm with suboptimal response to imatinib.American journal of clinical pathology
  • Case reportMasked Triple-Negative Polycythemia Vera Initially Presenting as Iron Deficiency and Pernicious Anemia.Cureus
  • Case reportNTRK1-Rearranged Cutaneous Non-Langerhans Cell Histiocytosis With Durable Response to TRK Inhibitor in a Patient With Primary Myelofibrosis.Journal of cutaneous pathology
  • ReviewTLR2 Signaling in Myeloproliferative Neoplasms: Pathophysiological Roles, Mutation-Dependent Heterogeneity, and the Differential Efficacy of Ruxolitinib.International journal of molecular sciences
  • ReviewMeasurable Residual Disease (MRD) Monitoring in Myeloproliferative Neoplasms.Cancers
  • Real-world treatment patterns, outcomes, and healthcare resource use for myelofibrosis in Brazil: Subgroup analysis of the METER study.Hematology, transfusion and cell therapy
  • Bone Marrow Cell Depletion in Myelofibrosis Is Associated With High-Risk Features and Shortened Survival: A Bone Marrow Pathology Group Study.Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
  • Case reportTropheryma whipplei Pneumonia with Myelofibrosis: A Rare Actinomycetia Case Report and Literature Review.Infection and drug resistance
  • Evaluating the Fiscal Burden of Essential Thrombocythemia in Sweden Through Application of a Government Perspective.ClinicoEconomics and outcomes research : CEOR
  • Case reportRetroperitoneal Hematoma in Essential Thrombocythaemia: A Diagnostic Challenge.La Clinica terapeutica
  • ReviewHow could calreticulin-targeting therapies change the myelofibrosis transplant paradigm?Bone marrow transplantation
  • Randomised trialFirstline treatment with ruxolitinib versus best available therapy in patients with polycythemia vera: results from the randomized RuxoBEAT trial.Blood cancer journal
  • ReviewNew Drugs in Myelofibrosis: Incremental Progress in Symptom Management Without Disease Modification.American journal of hematology
  • High Initial Dose and Accelerated vs. Slow Titration Ropeginterferon Alfa-2b for Polycythemia Vera: A Meta-Analysis.Blood advances
  • Observational studyLong-term hydroxyurea therapy alters bone marrow megakaryocyte morphology and associates with prognosis in myeloproliferative neoplasms.Annals of hematology
  • ReviewCalreticulin and myeloproliferative neoplasms: linking biology to targeted therapies.Expert review of clinical immunology
  • Predicting long-term survival in primary myelofibrosis.Leukemia
  • ReviewCardiac diagnostic modalities in polycythemia vera: A narrative review.The Journal of international medical research
  • Incidence of thrombosis and bleeding in patients with JAK2-positive myeloproliferative neoplasms receiving low-dose aspirin: a systematic review and meta-analysis.Journal of thrombosis and haemostasis : JTH
  • Rusfertide for Polycythemia Vera: Incremental Benefit Assessment.American journal of hematology
  • Case reportBiopsy-Proven Hepatic Extramedullary Hematopoiesis With Chronic Portal Vein Thrombosis in JAK2 V617F-Positive Prefibrotic Myelofibrosis: Contributors to Noncirrhotic Portal Hypertension.ACG case reports journal
  • Polycythemia Vera Transforming to Pure Erythroid Leukemia: A Diagnostic Mimic of Thrombotic Microangiopathy With High-Risk TP53 Biology.Case reports in hematology
  • Proteomic profiling of high purity extracellular vesicle subtypes from megakaryoblastic leukemia cells provides insights into myeloproliferative neoplasm biology.Extracellular vesicles and circulating nucleic acids
  • High-normal and mildly elevated bilirubin levels in prefibrotic primary myelofibrosis patients are associated with lower thrombotic risk.Scandinavian journal of clinical and laboratory investigation
  • Beyond Phlebotomy: Iron Homeostasis in the Next Phase of Polycythemia Vera Management.Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • Review"Beyond the Genetic Blueprint: Disrupting the Epitranscriptomic Code in Myeloproliferative Neoplasms".Experimental hematology
  • The Hyperviscous Heart: Reversible Cardiomyopathy in Polycythemia Vera.European heart journal. Cardiovascular Imaging
  • Case reportCombined central retinal and posterior ciliary artery occlusion in a young female with primary myelofibrosis and Sweet's syndrome: A case report.Taiwan journal of ophthalmology
  • Myelofibrosis end points and self-evident truths.Blood
  • Inflammasome, clonal stability and the thrombotic circuit in myeloproliferative neoplasms: an antecedent framework.Clinical and experimental medicine
  • Clinical Characteristics of Coexistent Chronic Myeloid Leukemia and BCR::ABL1 Negative Myeloproliferative Neoplasms: A Retrospective Study.Hematological oncology
  • American Society of Hematology 2026 Guidelines for the Management of Myelofibrosis in Adults.Blood advances
  • GuidelinePractical Management of Cytopenias in Patients with Myelofibrosis Adapted to the Portuguese Reality.Acta medica portuguesa
  • FDX1 is associated with CALR abundance and JAK-STAT-related inflammatory signaling in myeloproliferative neoplasms.Frontiers in oncology
  • VERIFY: A Phase III Trial of Rusfertide Versus Placebo in Phlebotomy-Dependent Patients With Polycythemia Vera Receiving Standard-of-Care Therapy.Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • Molecular Consequences and Targeting of PPM1D Overexpression in Myeloproliferative Neoplasms.Blood
  • Marrow hypercellularity is common and clinically neutral in essential thrombocythemia.Leukemia
  • Case reportDe novo development of JAK2V617F-positive polycythemia vera following allogeneic hematopoietic stem cell transplantation: a report of two rare cases.Upsala journal of medical sciences
  • PreprintCharacterization of Congestive Heart Failure Phenotype in a Murine Model of JAK2V617F-positive Myeloproliferative Neoplasm.bioRxiv : the preprint server for biology
  • Impact of Donor Age on Transplant Outcomes in Matched Unrelated Donor Transplantation for Myelofibrosis.Transplantation and cellular therapy
  • [Mutation characteristics and prognosis of SF3B1-mutated myeloid neoplasms: an analysis of 183 patients].Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
  • Comparative efficacy and safety of JAK inhibitor-based strategies in JAK inhibitor-naïve myelofibrosis: A systematic review and network meta-analysis.Therapeutic advances in hematology
  • ReviewTargeted literature review to understand the patient experience of essential thrombocythemia and evaluate existing clinical outcome assessment measures.Journal of patient-reported outcomes
  • Systematic reviewEfficacy and safety of ropeginterferon in myeloproliferative neoplasms: a systematic review and meta-analysis.Frontiers in pharmacology
  • Roginolisib in Combination with JAK Inhibitors in Patients with Myelofibrosis Who are Unresponsive to Approved JAK Inhibitors (Study HEMA-MED) - A Trial in Progress.OncoTargets and therapy
  • Outcome heterogeneity in CALR-mutated myeloproliferative neoplasms.British journal of haematology
  • ReviewCO-Rebreathing in Essential Thrombocythemia and Polycythemia Vera. A Revival of an Old Methodology to Improve Diagnosis and Phlebotomy Decisions.Cancer medicine
  • Navitoclax monotherapy or in combination with ruxolitinib in patients with JAK2 inhibitor-treated myelofibrosis: results from the phase 2 REFINE and phase 3 TRANSFORM-2 studies.Leukemia & lymphoma
  • Aberrant erythrocyte rigidity in JAK2V617F myeloproliferative neoplasms underlies concurrent thrombosis and hemorrhage.Science translational medicine
  • HMGA1 and HMGA2: epigenetic regulators in myeloproliferative neoplasms and novel platelet transcriptomic biomarkers of myelofibrosis.Leukemia
  • KT-253, a highly potent and selective MDM2 protein degrader, eliminates malignant myelofibrosis stem/progenitor cells.Leukemia
  • Impact of Metformin on the Incidence of Thrombosis in Older Adults with Polycythemia Vera or Essential Thrombocythemia and Diabetes.Blood advances
  • Peri-transplant ruxolitinib in myelofibrosis patients undergoing αβTCR and CD19-depleted stem cell transplantation.Bone marrow transplantation
  • Case reportConcurrent Diabetic Muscle Infarction and JAK2 Exon 12-Positive Polycythemia Vera: A Rare Dual Diagnosis.Cureus
  • Case reportMerkel cell carcinoma in a patient on ruxolitinib treatment for polycythemia vera.JAAD case reports
  • Long-term eGFR decline in polycythemia vera compared with secondary polycythemia: a retrospective longitudinal cohort study.Clinical and experimental nephrology
  • Increased glioblastoma risk in patients with myeloproliferative neoplasms and myelodysplastic syndromes.Clinical and experimental medicine
  • Obstetric and thrombotic outcomes among pregnant patients with myeloproliferative neoplasms: a propensity score matched real-world analysis.Annals of hematology
  • Extensive Cerebral Venous Sinus Thrombosis With Obstructive Hydrocephalus in a Young Female With Underlying Essential Thrombocythemia: A Case Report.Clinical case reports
  • Tracing the Clonal Origin of VEXAS: Insights from cases of myelofibrosis with concurrent UBA1 and JAK2 V617F mutation.Leukemia research
  • Clinicopathological Features and Exploratory Outcome Associations of Bone Marrow Fibrosis in Newly Diagnosed Acute Lymphoblastic Leukemia: A Single-Center Retrospective Cohort Study.Cancer medicine
  • Elucidating Mechanisms Underlying Fibrocyte-Mediated Myelofibrosis Induction in Myelodysplastic Syndromes.Frontiers in bioscience (Landmark edition)
  • Case reportMasked polycythaemia vera presenting with extensive splanchnic venous thrombosis and mesenteric ischaemia.BMJ case reports
  • ReviewMegakaryocytes in myelofibrosis: mechanisms of fibrotic niche remodeling and therapeutic implications.Biomarker research
  • The First Molecular Profiling of JAK2 Exon 12 and Flanking Intronic Sequences in Indonesia.Asian Pacific journal of cancer prevention : APJCP
  • Pediatric Essential Thrombocythemia With a Novel CALR Mutation: A Case Report.EJHaem
  • Meta-analysisExposure-Response Analyses of Ropeginterferon Alfa-2b in Essential Thrombocythemia.Journal of clinical pharmacology
  • ReviewPIM1 in myeloproliferative neoplasms: potential pathogenic and therapeutic implications.Leukemia
  • [Study on the Effect of Treatment Regiman Combined with Ruxolitinib on MPN Patients with Myelofibrosis and the Influencing Factors of Mutated Gene Load].Zhongguo shi yan xue ye xue za zhi
  • CALR-mutated myeloproliferative neoplasms: Refining molecular risk beyond the driver.British journal of haematology
  • ReviewReassessing the clinical value of momelotinib in myelofibrosis: An ESMO-MCBS:H-based appraisal of SIMPLIFY-1 and MOMENTUM.Critical reviews in oncology/hematology
  • ReviewThe Roles of Genetic and Epigenetic Abnormalities in Essential Thrombocythemia.Genes
  • Systematic reviewATM mutations in myelodysplastic neoplasms, acute myeloid leukemia, and myeloproliferative neoplasms: a systematic review.Medical oncology (Northwood, London, England)
  • Synchronous Triple Malignancy Presentation of Multiple Myeloma and Prefibrotic Primary Myelofibrosis in a Patient With Mucinous Breast Carcinoma: A Case Report From Rural South Africa.Case reports in hematology
  • Comment on "iMTSS: an Integrated Framework for Biology- and Patient-Driven Prognosis in Myelofibrosis Undergoing Transplantation".Transplantation and cellular therapy
  • ReviewMolecular Abnormalities and Associated Clinical Features in Polycythemia Vera.Medical sciences (Basel, Switzerland)
  • Dual-Driver Myeloproliferative Neoplasm: Concurrent p190 BCR::ABL1 CML and JAK2 V617F Mutation: A Case Report and Literature Review.Case reports in hematology
  • Reply to: Comment on "iMTSS: An Integrated Framework for Biology- and Patient-Driven Prognosis in Myelofibrosis Undergoing Transplantation".Transplantation and cellular therapy
  • Integrating Next Generation sequencing into the risk assessment of primary myelofibrosis.Hematology, transfusion and cell therapy
  • Fibrocytes take the wheel in myelofibrosis.Blood
  • Case reportJAK2-Positive Myeloproliferative Neoplasm: Polycythaemia Vera Presenting As Budd-Chiari Syndrome.Cureus
  • ReviewAllogeneic Hematopoietic Stem Cell Transplantation in Myelofibrosis: Evolving Indications, Conditioning Strategies, and Outcomes.Hematology reports
  • Clinicopathologic Characteristics of Somatic TP53 Mutations in Philadelphia Chromosome-Negative Myeloproliferative Neoplasms: A Systematic Review.EJHaem
  • Elevated P-RBC complexes are associated with thrombotic risk and diagnostic potential in myeloproliferative neoplasms: a retrospective cohort study.American journal of translational research
  • Spleen-derived circulating intercellular adhesion molecule 2 promotes osteosclerosis in chronic myelofibrosis.Bone research
  • Ophthalmological and epidemiological profiles of Brazilian patients with philadelphia-negative Myeloproliferative neoplasms.Hematology, transfusion and cell therapy
  • Mycobacterium avium Complex Pulmonary Disease as a Clinical Signal of Host Vulnerability in Advanced Myelofibrosis.Clinical case reports
  • Modifiable determinants of adherence to tyrosine kinase inhibitors in classical myeloproliferative neoplasms: A mixed-methods systematic review protocol.PloS one
  • ReviewMolecular Response, Event-Free Survival, and Treatment-Free Remission in Myeloproliferative Neoplasms: Update and Review with Insights from MPN Asia 2026.Current hematologic malignancy reports
  • iMTSS: An Integrated Framework for Biology- and Patient-Driven Prognosis in Myelofibrosis Undergoing Transplantation.Transplantation and cellular therapy
  • Interferon-α vs hydroxyurea in patients with myeloproliferative neoplasms (DALIAH): a multicentre, randomised, open-label, phase 3 trial in Denmark.EClinicalMedicine
  • [Management of polycythemia vera and essential thrombocythemia in real life: A French perspective].Bulletin du cancer
  • ReviewThe Current Landscape of Pulmonary Hypertension in Myeloproliferative Neoplasms.Cancers
  • Case reportCase Report: Primary myelofibrosis presenting with non-cirrhotic portal hypertension and initially misdiagnosed as cirrhosis.Frontiers in medicine
  • Machine Learning-Assisted SHG Morphometry Reveals Distinct Collagen Microarchitectures of Trabecular Bone and Fibrosis in Bone Marrow Biopsies.International journal of molecular sciences
  • Inhibition of RhoA-mediated secretory autophagy in megakaryocytes mitigates myelofibrosis in mice.Nature communications
  • Adaptations in pacritinib usage for myelofibrosis and thrombocytopenia since FDA approval.Expert review of hematology
  • Optimized dosing of momelotinib in myelofibrosis through quantitative medicine: a clinical commentary.Leukemia & lymphoma
  • Congenital Hemophilia-A With High-Titer Inhibitor and Essential Thrombocythemia: A Rare Coexistence.Haemophilia : the official journal of the World Federation of Hemophilia
  • ReviewManaging thrombotic risk in myeloproliferative disorders.Expert review of hematology
  • Case report[Aortic Valve Replacement Associated With Essential Thrombocythemia:Report of a Case].Kyobu geka. The Japanese journal of thoracic surgery
  • ETV6::LYN Fusion in Eosinophilic Myeloproliferative Neoplasm: A Rare Mimic of Chronic Myeloid Leukemia Revealed by FISH and RNA Sequencing.Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion
  • Prevalence and Real-World Clinical Outcomes of Hydroxyurea Resistance and Intolerance in Polycythemia Vera and Essential Thrombocythemia: A Single-Centre Experience.Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion
  • MPL-mutated Primary Myelofibrosis and Multiple myeloma - A Rare Coexistence.Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion
  • Case reportBeyond the Bone Marrow: A Case Report of Extramedullary Hematopoiesis in Advanced Primary Myelofibrosis.Cureus
  • Impact of bone marrow fibrosis on disease characteristics and outcomes in newly diagnosed multiple myeloma patients.Current research in translational medicine
  • ReviewDissecting Bone Marrow Fibrosis in Philadelphia-Negative Myeloproliferative Neoplasms: Multiple Roads Lead to Rome.Hematological oncology
  • [Comparative study of the prognostic value of survival prognostic scoring systems in patients with essential thrombocythemia: IPSET, MIPSS-ET, AAA, and AAA].Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
  • PMDA regulatory update on approval and revision of the precautions for use of anticancer drugs in Japan; sevabertinib for lung cancer, gemcitabine intravesical system and durvalumab for bladder cancer, azacitidine for leukemia, cemiplimab for skin cancer, and ropeginterferon alfa-2b for essential thrombocythemia.International journal of clinical oncology
  • Age as a core disease modifier: Distinct clinical, molecular and prognostic landscapes of essential thrombocythaemia in adolescents and young adults.British journal of haematology
  • ReviewFrom standardization to precision medicine: Evolution of European Leukemianet recommendations in Philadelphia-negative myeloproliferative neoplasms.Leukemia research
  • Mutational landscape of classical myeloproliferative neoplasms in the Western Cape Province, South Africa.African journal of laboratory medicine
  • Randomised trialOutcomes of patients with myelofibrosis treated with ruxolitinib and anemia-supporting medications.Hematology (Amsterdam, Netherlands)
  • Case reportExtramedullary hematopoiesis presenting as a large adrenal mass mimicking adrenocortical carcinoma in a primary myelofibrosis patient: A case report.Urology case reports
  • Endoscopic Healing of Ileal Extramedullary Hematopoiesis in Primary Myelofibrosis After Hydroxyurea.Gastrointestinal endoscopy
  • Case report[Abdominal Pain as the First Manifestation of Rare Hematological Diseases: A Case Series].Harefuah
  • ReviewClosing the disease modification gap: Emerging therapies in myelofibrosis beyond JAK inhibition.Seminars in hematology
  • ReviewInflammatory Network Architecture Across Bone Marrow Failure: An Immune-Genetic Continuum.Frontiers in bioscience (Landmark edition)
  • Cutaneous Clue to Clonal Evolution: Sweet's Syndrome Heralding Hematologic Progression in Essential Thrombocythemia.Case reports in hematology
  • Beyond compensation: Organized pathological hematopoiesis in the myelofibrotic spleen.Cell stem cell
  • Clinical and genetic features of Ph-negative myeloproliferative neoplasms with dual-driver gene positivity.Hematology (Amsterdam, Netherlands)
  • Patient-reported outcomes of symptom burden and quality of life in patients with polycythemia vera and essential thrombocythemia in Korea: A cross-sectional study.Medicine
  • Following the Genetic Breadcrumbs of MPNs.Cancer discovery
  • Case reportEfficacy and Safety of Ropeginterferon Alfa-2b in Pregnant Women With Myeloproliferative Neoplasms: Case Series of Three Subtypes and Review.Journal of Korean medical science
  • Review[Experimental model systems of primary myelofibrosis].Sheng li xue bao : [Acta physiologica Sinica]
  • ReviewFrom Immune Dysfunction to Clinical Risk: Infections in Myelofibrosis.European journal of haematology
  • ReviewWhat Explains the Pattern of Fibrosis in Chronic Graft-Versus-Host Disease?Clinical transplantation
  • Incidence, prevalence, and survival outcomes of patients with myeloproliferative neoplasms in the United States: a Surveillance, Epidemiology, and End Results (SEER) database analysis, years 2000-2021.Leukemia
  • Bone Marrow Fibrosis as a Predictor of Extramedullary Disease in Multiple Myeloma.European journal of haematology
  • Observational studyNurse-Led Patient-Reported Outcome Assessment of Symptom Burden and Quality of Life in Myeloproliferative Neoplasms: An Observational Study.Nursing open
  • Case report[Thiotepa-busulfan-fludarabine conditioning in allogeneic hematopoietic stem cell transplantation for blast-phase myeloproliferative neoplasm].[Rinsho ketsueki] The Japanese journal of clinical hematology
  • Case reportMyeloid sarcoma as EM blast crisis in BCR-ABL1 e6a2+ CML with myelofibrosis and TB: a case report.Open life sciences
  • NFкB pathway suppression as a key driver of pacritinib response in high-risk myelofibrosis.British journal of haematology
  • ReviewTargeting the hepcidin-ferroportin axis in polycythemia vera: a complementary approach to clone-directed therapies.Blood reviews
  • Complete Hematological Response Coupled with Molecular Response in Polycythemia Vera Treatment with Ropeginterferon Alfa-2b.Life (Basel, Switzerland)
  • ReviewInflammatory and Immune Microenvironment in Myeloproliferative Neoplasms: Pathogenic Mechanisms and Therapeutic Opportunities.Cancers
  • Final results of a phase II study of the combination of azacitidine and ruxolitinib in patients with myelofibrosis.Haematologica
  • Synchronous Coexistence of JAK2 V617F-Positive Essential Thrombocythemia and IgG Kappa Multiple Myeloma in an Octogenarian Patient: A Case Report.Case reports in medicine
  • Management of polycythemia vera to reduce thrombotic events and mortality with phlebotomy and cytoreductive therapy in veterans affairs healthcare system.Cancer treatment and research communications
  • Deep learning differentiates myeloproliferative neoplasms and predicts JAK2 and CALR mutations from bone marrow smears.Annals of hematology
  • Neutrophil-to-lymphocyte ratio as a gene-specific biomarker of JAK2-driven inflammation across CHIP and myeloproliferative neoplasms.Frontiers in oncology
  • ReviewBlood or marrow transplantation and cellular therapies in myeloproliferative neoplasms: A comprehensive review.Seminars in hematology
  • Case reportMyeloid/Lymphoid Neoplasm with FGFR1::ZMYM2 Rearrangement Presenting as T-Cell Acute Lymphoblastic Lymphoma with Concurrent Myeloproliferative Neoplasm: A Case Report.Hematology reports
  • Transjugular Mesenteric-Caval Shunt for Cavernous Transformation of the Portal Vein Secondary to Myelofibrosis.Journal of vascular and interventional radiology : JVIR
  • Case reportTorsion and Rupture of a Wandering Pelvic Accessory Spleen Associated with Essential Thrombocythemia: A Case Report.Surgical case reports
  • Lupus Nephritis Exhibiting a Membranoproliferative Pattern in Primary Myelofibrosis: A Diagnostic Challenge of Occult SLE.Case reports in nephrology
  • Splenic extramedullary hematopoiesis in myelofibrosis is shaped by transcriptomic and epigenetic dysregulation.Cell stem cell
  • Case reportDengue Fever Unmasking JAK2 Mutation-Related Polycythemia Vera Presenting With Extensive Splanchnic Venous Thrombosis and Hemorrhagic Complications: A Diagnostic and Therapeutic Challenge.Cureus
  • Spatial profiling of the spleen in mouse and human myelofibrosis reveals complement-driven immune-stromal interactions as a therapeutic target.Cell stem cell
  • Sequential High-Dose Ruxolitinib and Low-Dose Splenic Irradiation for Pretransplant Management of Splenomegaly Before Allogeneic Hematopoietic Cell Transplantation With Fludarabine/Busulfan-Based Conditioning in Myelofibrosis.EJHaem
  • Homozygosity of germ line JAK2 46/1 haplotype contributes to phenotype and outcome diversity in polycythemia vera.Blood neoplasia
  • ReviewEpigenetic Rewiring and Context-Dependent Therapeutic Vulnerabilities in Myeloproliferative Neoplasms.Hematological oncology
  • Longitudinal prospective analysis of organ stiffness and cardiac function in patients with myelofibrosis treated with ruxolitinib type of study: Prospective single-center cohort study.Therapeutic advances in hematology
  • Immune and cytokine landscape differs between cytopenic and proliferative phenotypes in primary myelofibrosis.Therapeutic advances in hematology
  • Impact of cytoreductive therapy in myeloproliferative neoplasm-associated splanchnic vein thrombosis.Blood advances
  • ReviewImmunotherapeutic targeting of calreticulin mutant myeloproliferative neoplasms.Leukemia
  • Splanchnic vein thrombosis resulting from myeloproliferative neoplasm: same clot, different story?Journal of thrombosis and haemostasis : JTH
  • ReviewMyeloproliferative Neoplasms.The New England journal of medicine
  • Sapablursen for Erythrocytosis Control in Patients with Polycythemia Vera.Blood
  • External validation of the AAA+ survival model in a large Chinese cohort with essential thrombocythaemia.British journal of haematology
  • Case reportChoreiform Movements and Pachymeningeal Enhancement in an Elderly Patient With Abnormal Blood Counts: A Case Report and Review of Literature.Journal of investigative medicine high impact case reports
  • ReviewRole of JAK2 V617F in Myeloproliferative Neoplasms: From Mutation to Manifestation: A Review.Nigerian medical journal : journal of the Nigeria Medical Association
  • Adolescent and Young Adult versus Older Adult Philadelphia-Negative Myeloproliferative Neoplasms: A Single-Center Experience from the MENA Region.Journal of blood medicine
  • ReviewJanus kinase inhibitors after ruxolitinib failure in myelofibrosis: A systematic review and pooled analysis of phase 3 efficacy and integrated safety across clinical trials and real-world evidence.British journal of haematology
  • Case reportNew-Onset Raynaud Phenomenon during Ropeginterferon Alfa-2b Therapy for Polycythemia Vera: A Case Report and Review of the Literature.Case reports in oncology
  • ReviewSOHO State of the Art Updates and Next Questions| Individualizing Treatment Selection in Myelofibrosis.Clinical lymphoma, myeloma & leukemia
  • Comparative Evaluation of Quantitative Real-Time PCR and a Laboratory-Developed Chip-Based Real-Time Digital PCR for JAK2 V617F Allele Burden in Myeloproliferative Neoplasms.Diagnostics (Basel, Switzerland)
  • Collagen Turnover Is Associated with Disease Severity, Bone Marrow Fibrosis, and the JAK2V617F Variant Allele Frequency in Myeloproliferative Neoplasms.Cancers
  • ReviewSOHO State of the Art Updates and Next Questions | Predictive Markers for Ruxolitinib in Myelofibrosis.Clinical lymphoma, myeloma & leukemia
  • Case reportDiagnostic delay of veno-occlusive disease in a myelofibrosis patient with pre-transplant transjugular intrahepatic portosystemic shunt: a case report.Frontiers in oncology
  • Case reportEarly device-related thrombosis after WATCHMAN™ FLX Pro implantation requiring surgical excision in essential thrombocythemia.Journal of cardiology cases
  • Case reportA patient with myelodysplastic/myeloproliferative neoplasm with neutrophilia (MDS/MPN-N) harboring a DDX41 germline mutation: a case report.Frontiers in oncology
  • Philadelphia-negative myeloproliferative neoplasms and acquired von Willebrand syndrome: only pertinent at diagnosis?Research and practice in thrombosis and haemostasis
  • Targeted Next-Generation Sequencing of JAK2, CALR, and MPL in 10 326 Patients With Suspected Myeloproliferative Neoplasm.American journal of hematology
  • Case reportFirst Philippine report of myeloproliferative neoplasms with concurrent JAK2 and BCR::ABL1 mutations.BMJ case reports
  • ReviewThe thrombopoietin receptor in myeloproliferative neoplasms: A unifying mechanism of disease pathogenesis and therapeutic targeting.Seminars in hematology